Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
409-03-009 Registered Abstract

Real-World Validation of Automated 3D-MRF Classification for Alzheimer's Diagnosis

Primary: Neuro - Alzheimer's Disease
Secondary: Acquisition & Reconstruction - Quantitative Imaging: relaxometry, multi-parametric, MR Fingerprinting, and synthetic MRI
409-03-009 · Quantitative Imaging: Applications · Tuesday, 12 May, 1:40 PM–3:30 PM · Meeting Room 2.40
Keywords: Diagnosis/Prediction Multiparametric imaging Neurodegenerative Disease Classification Automated segmentation Magnetic resonance fingerprinting
Accepted
Andrew Dupuis 1, Sree Gongala1, Rasim Boyacioglu2,3, Chaitra Badve3, Mark Griswold1,2,3
1Department of Radiology, Case Western Reserve University, Cleveland, United States of America
2Department of Biomedical Engineering, Case Western Reserve University, Cleveland, United States of America
3Department of Radiology, University Hospitals, Cleveland, United States of America
Presenting Author: Andrew Dupuis

Synopsis

Motivation:
Goals:
Approach:
Hypothesis:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837–845. PMID: 3203132. [pmid]
2. Brewer JB, Magda S, Airriess C, Smith ME. Fully-automated quantification of regional brain volumes for improved detection of focal atrophy in Alzheimer disease. AJNR Am J Neuroradiol. 2009;30(3):578–580. doi:10.3174/ajnr.A1402 [doi]
3. Struyfs H, Sima DM, Wittens M, et al. Automated MRI volumetry as a diagnostic tool for Alzheimer's disease: Validation of icobrain dm. NeuroImage Clin. 2020;26:102243. doi:10.1016/j.nicl.2020.102243 [doi]
4. Wittens MMJ, Sima DM, Houbrechts R, et al. Diagnostic performance of automated MRI volumetry by icobrain dm for Alzheimer's disease in a clinical setting: a REMEMBER study. J Alzheimers Dis. 2021;83(2):623–639. doi:10.3233/JAD-210450 [doi]
5. Odusami M, Maskeliūnas R, Damaševičius R, Krilavičius T. Analysis of features of Alzheimer's disease: detection of early stage from functional brain changes in magnetic resonance images using a finetuned ResNet18 network. Diagnostics (Basel). 2021;11(6):1071. doi:10.3390/diagnostics11061071 [doi]
6. Nicholas PJ, To A, Tanglay O, Young IM, Sughrue ME, Doyen S. Using a ResNet-18 network to detect features of Alzheimer's disease on functional magnetic resonance imaging: a failed replication. Comment on Odusami et al. Diagnostics 2021, 11, 1071. Diagnostics (Basel). 2022;12(5):1094. doi:10.3390/diagnostics12051094 [doi]
7. Qiu S, Joshi PS, Miller MI, et al. Development and validation of an interpretable deep learning framework for Alzheimer's disease classification. Brain. 2020;143(6):1920–1933. doi:10.1093/brain/awaa137 [doi]
8. Arranz J, Zhu N, Rubio-Guerra S, et al. Diagnostic performance of plasma pTau217, pTau181, Aβ1-42 and Aβ1-40 in the LUMIPULSE automated platform for the detection of Alzheimer disease. Alzheimers Res Ther. 2024;16(1):139. doi:10.1186/s13195-024-01513-9 [doi]
9. Leisgang Osse AM, Zhou Y, Kinney JW, et al. Biomarkers in Alzheimer's disease clinical trials: 2025. Alzheimers Dement (N Y). 2026;12(1):e70217. doi:10.1002/trc2.70217 [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/409-03-009